
To evaluate the zzso zzso stimulating properties of zzso a novel, zzso synthetic zzso for the treatment of anemia associated with chronic kidney disease and zzso 

The in zzso activity of zzso was assessed in competitive zzso zzso signal zzso and zzso zzso and in zzso zzso zzso with zzso cells zzso from human bone zzso zzso and zzso were evaluated in zzso zzso and a rat chronic zzso zzso zzso model following single zzso zzso and zzso were also evaluated following repeat administration in zzso 

zzso binds and activates the zzso zzso and causes proliferation and differentiation of zzso zzso zzso zzso circulatory persistence of zzso is observed in rats and zzso In a rat zzso model, zzso exhibited twofold lower clearance than in the normal zzso with hypothesis consistent with zzso being zzso at least zzso via the zzso A zzso rise in zzso zzso and duration of response was observed following single administration in rats and zzso zzso was able to alleviate anemia in an experimental zzso zzso zzso Repeat intravenous zzso and subcutaneous zzso administration in rats yielded similar zzso responses, with no zzso zzso being zzso 

zzso is a potent zzso stimulating agent with a prolonged zzso and slow clearance zzso It is anticipated that similar prolonged clearance and activity will be observed in the clinic, potentially enabling dosing intervals of 3 to 4 weeks that may translate into improved patient convenience for the treatment of zzso 

